Published in 2016 in the Stanford Social Innovation Review, this article discusses the highly effective volume guarantees supplied to two major pharmaceutical firms in 2012 by the Bill and Melinda Gates Foundation (BMGF) and other funders.
The guarantees were put in place to roughly double the supply and halve the price of contraceptive implants – the results have since surpassed expectations. In the first three years of the guarantees the annual run rate more than doubled from 4.7 to almost 10 million, and price reductions saved more than $240 million for global public health donors.
The article emphasises that even with lower prices, higher volumes can drive bigger profits—a classic win-win for both consumers and producers.
Read: SSIR’S GUARANTEED IMPACT
Sign up for our quarterly updates to find out more about how our work is making healthcare products more affordable and accessible.
